Amgen Osteoporosis Drug Denosumab Proven Effective

September 17, 2008

Amgen Inc. appears to have a winner with their new bone drug known as denosumab...Washington (ChattahBox) – Amgen Inc. appears to have a winner with their new bone drug known as denosumab.

The company put out a new trial on Tuesday, presenting it at the annual meeting of the American Society for Bone and Mineral Research.

The trial revealed that the drug is very effective in helping deal with bone problems.

Researchers carried out the trial on 7,800 post-menopausal women over a three-year period.

Half of the women took a placebo, while the other half took the Amgen drug.

The Amgen drug was found to reduce the risk of vertebral fractures by 68% for the women, and hip fractures by 40%.

The drug has already been shown to be more effective than Merck & Co.’s Fosamax in a previous study.


Comments

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.